Integrated Pulmonary Index Monitoring on the Incidence of Hypoxemia in Elderly Patients With Painless Colonoscopy
Effect of Continuous Integrated Pulmonary Index Monitoring on the Incidence of Hypoxemia in Elderly Patients With Painless Colonoscopy
1 other identifier
interventional
153
1 country
1
Brief Summary
The purpose of this clinical trial is to integrated pulmonary index to see if there is an effect on the incidence of hypoxemia during painless colonoscopy in older patients. Does composite pulmonary index monitoring reduce the incidence of hypoxemia? Is there a relationship between the value of the integrated pulmonary index and the patient's pulse oximetry? Continuous monitoring of the integrated pulmonary index in the experimental group was compared with the control group (no detection of the composite lung index) to see if continuous monitoring of the composite pulmonary index could reduce the incidence of hypoxemia in elderly patients. Participants will: Oxygen is provided through the nasal cannula, and respiratory parameters (end-tidal carbon dioxide partial pressure (PetCO2), pulse rate \[PR\], oxygen saturation (SpO2), and respiratory rate (RR) are obtained. The monitor calculates a integrated pulmonary index value (1-10) through mathematical operations.Different measures are taken according to different composite lung indexes, such as when the IPI is ≤6, the patient's jaw is immediately lifted, the oxygen flow rate increases to 6L·min-1, and if the SpO2 continues to decrease by \<90%, the anesthesia mask is pressurized and ventilated. Record their vital signs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 23, 2025
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedDecember 1, 2025
November 1, 2025
4 months
May 5, 2025
November 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of hypotension
the number of patients experiencing low blood pressure
Perioperative
Secondary Outcomes (1)
Adverse reactions (dizziness, nausea, vomiting, etc.)
Perioperative
Study Arms (2)
P group
EXPERIMENTALNasal cannula oxygen inhalation, oxygen flow rate 3-4L/min, monitor the integrated pulmonary index and SpO2.
C group
NO INTERVENTIONNasal cannula oxygen inhalation, oxygen flow rate 3-4L/min,monitor the SpO2,
Interventions
When the IPI is ≤ 6, the patient's jaw is immediately lifted, the oxygen flow rate increases to 6L·min-1, and if the SpO2 continues to decrease by \<90%, the anesthesia mask is pressurized and ventilated.
Eligibility Criteria
You may qualify if:
- Patients who were selected for non-intubated painless colonoscopy;
- Age≥ 65 years;
- American Society of Anesthesiologists (ASA) grade I\~III;
- Conscious, no cognitive dysfunction and other mental illnesses;
- Voluntarily participate in this study and sign the informed consent form
You may not qualify if:
- Patients with severe circulatory system diseases, respiratory diseases, and central nervous system diseases;
- Patients with severe abnormal liver and kidney function;
- Those who are allergic to any of the drugs used in the study;
- Participated in other clinical studies within the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First People's Hospital of Lianyungang City
Lianyungang, Jiangsu, 222000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2025
First Posted
May 23, 2025
Study Start
June 1, 2025
Primary Completion
October 1, 2025
Study Completion
October 31, 2025
Last Updated
December 1, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share